Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Lttl

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Lttl head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 161 · Grade C

Lttl

Visit Lttl Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 68 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Lttl a bad call — it's best for readers who want the whole price matrix in front of them before they answer a single question, and who will check which term a headline figure is attached to before treating it as a monthly bill. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
66
Supply Reliability
95
71
Transparency
90
72
Access Breadth
93
56
Clinical Oversight
92
76
Track Record
88
65
CoreAge RxBrief Score 94 · 68Lttl

Price, coverage & the tracker

CoreAge RxLttl
Brief Score94/100 (A)68/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$199/mo (month-to-month, all doses, compounded; prepay tiers lower)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$279/mo (month-to-month, all doses, compounded; prepay tiers lower)

CoverageUS only; restrictions by state, confirmed at intakeCoverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyYes
On the trackerStableprice stableStableprice stable

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Lttl: Month-to-month prices are $199 for semaglutide and $279 for tirzepatide. The advertised $129 monthly semaglutide price requires twelve-month prepayment.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.